Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Index by author

March 1, 2011; Volume 52,Issue 3
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Nagengast, Wouter B.

    1. You have access
      Total Abdominal 18F-FDG Uptake Reflects Intestinal Adenoma Burden in Apc Mutant Mice
      Dianne M. Heijink, Jan H. Kleibeuker, Wouter B. Nagengast, Dorenda Oosterhuis, Adrienne H. Brouwers, Jan J. Koornstra, Steven de Jong and Elisabeth G.E. de Vries
      Journal of Nuclear Medicine March 1, 2011, 52 (3) 431-436; DOI: https://doi.org/10.2967/jnumed.110.083956
  2. Naji, Ali

    1. You have access
      Beta-cell Imaging: Opportunities and Limitations
      Thomas C. Kwee, Sandip Basu, Babak Saboury, Drew A. Torigian, Ali Naji and Abass Alavi
      Journal of Nuclear Medicine March 1, 2011, 52 (3) 493; DOI: https://doi.org/10.2967/jnumed.110.085530
  3. Necib, Hatem

    1. You have access
      Detection and Characterization of Tumor Changes in 18F-FDG PET Patient Monitoring Using Parametric Imaging
      Hatem Necib, Camilo Garcia, Antoine Wagner, Bruno Vanderlinden, Patrick Emonts, Alain Hendlisz, Patrick Flamen and Irène Buvat
      Journal of Nuclear Medicine March 1, 2011, 52 (3) 354-361; DOI: https://doi.org/10.2967/jnumed.110.080150
  4. Novelline, Robert A.

    1. You have access
      Jobs and New Initiatives in Nuclear Medicine Education
      Jay A. Harolds, Robert A. Novelline, Milton J. Guiberteau, Darlene Metter and M. Elizabeth Oates
      Journal of Nuclear Medicine March 1, 2011, 52 (3) 17N-23N;
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 52 (3)
Journal of Nuclear Medicine
Vol. 52, Issue 3
March 1, 2011
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire